Mackwell Solutions has entered into a deal with Medi-Immune to design, develop and manufacture a range of products based on their innovative disinfection technology, which has widespread application where protection against airborne infections is required.
Ian Mutton, Head of Mackwell Solutions, is excited about the new partnership, "We are thrilled about our partnership with Medi-Immune. A great start for the new solutions side to the Mackwell business and the catalyst for our entry into new markets. The combination of knowledge and skills between the two companies will enable us to develop some really exciting and innovative products. It's great to work on innovations that will make a significant difference in these challenging times, and we look forward to announcing the first of these products very soon."
Equally John Willcocks of Medi-Immune, can see a great future from the support given by the Mackwell Solutions team, "We are delighted to have formed this new partnership with Mackwell Solutions. For us it is the perfect match as Mackwell has been very quick to understand our mission and their enthusiasm and devotion is outstanding. It's also great to be working with another like-minded British company on this."
Medi-Immune Limited is a UK-based research and development company that has set out to create ground-breaking technology to protect those who are working to protect us in pandemics, outbreaks and bioterrorism. COVID-19 has shocked everyone and shown the devastating changes that an easily transmissible airborne pathogen can bring.
By partnering with Mackwell Solutions, Medi-Immune now has the ability to take its patented technology quickly to market and provide a valuable contribution to the health and emergency sectors. Listed as one of 20 most innovative companies to watch by Business Week in 2019, Medi-Immune has broad scientific and engineering expertise in virology, immunology, medical device technology, mechanical engineering and UV germicidal science.
